Prevalence of mental disorders in Peruvian population with COVID-19 attended in the program "Te Cuido Perú".
Keywords:
Prevalence; mental disorders; anxiety; depression; COVID-19; Peru.Abstract
Objetive: This study aims to determine the prevalence of mental disorders in the Peruvian population attended via telephone calls in the "Te cuido Perú" program in the context of the COVID-19 pandemic. Methodology: Descriptive and cross-sectional study, 2,375 people with a diagnosis of COVID-19 attended via telephone call in this program participated. Results: The results indicate that 82.1% of the sample attended presented some type of mental disorder. The most prevalent disorders were anxiety (34.15%), depression (25.22%), acute stress (13.81%), panic disorder (3.24%), adjustment disorder (2.44%), eating disorders (1.64%), obsessive compulsive disorder (0.8%) and other mental disorders (0.8%). Conclusions: These findings suggest the need to establish promotion, prevention, and psychotherapeutic treatment actions to provide better psychological tools to the affected and at-risk population, to enable them to manage and strengthen their coping and adaptation capacity in the face of the COVID-19 pandemic.
Downloads
References
Romero-Sacoto L, Mesa-Cano I, Estrella M, Ramírez-Coronel A. El equipo de protección personal para la atención al paciente con COVID-19: revisión sistemática. Arch Venez Farmacol y Ter. 2021;40(7):666-674.
Peñafiel-León JE, Ramírez-Coronel AA, Mesa-Cano IC, Martínez-Suárez PC. Impacto psicologico, resiliencia y afrontamiento del personal de salud durante la pandemia por COVID-19. Arch Venez Farmacol y Ter. 2021;40(3):202-211.
Javed B, Sarwer A, Soto EB, Mashwani Z. The coronavirus (COVID-19) pandemic’s impact on mental health. Int J Health Plann Manage. 2020;35(5):993-996.
Javed B, Sarwer A, Soto EB, Mashwani ZUR. Is Pakistan’s Response to Coronavirus (SARS-CoV-2) Adequate to Prevent an Outbreak? Front Med. 2020;7:7-10.
Huarcaya J. Consideraciones sobre la salud mental en la pandemia de COVID-19. Rev Peru Med Exp Salud Publica. 2020;37(2):327-334.
Huarcaya J, Villarreal D, Podestà A, Luna-Cuadros M. Propiedades psicométricas de una versión en español de la escala de miedo al COVID-19 en población general de Lima, Perú. Int J Ment Health Addict. 2020;1(1):1-14.
Mejia C, Garay-Rios L, Enriquez-Anco M, Moreno A, Huaytán A, Huancahuari N, et al. Percepción de miedo o exageración que transmiten los medios de comunicación en la población peruana durante la pandemia de la COVID-19. Rev Cuba invest bioméd. 2020;39(2):1-20.
Morocho A, Espinoza C, Estrada E, Jiménez A, Telenchana F, Rojas J, et al. Salud mental de los pacientes con enfermedades crónicas durante la pandemia por COVID-19. Sindr Cardiometabólico y enfermedades crónicas Degener. 2020;X(1):20-24.
Chen Y, Huang X, Zhang C, An Y, Liang Y, Yang Y, et al. Prevalence and predictors of posttraumatic stress disorder, depression and anxiety among hospitalized patients with coronavirus disease 2019 in China. BMC Psychiatry. 2021;21(1):1-8.
Guo WP, Min Q, Gu WW, Yu L, Xiao X, Yi W, et al. Prevalence of mental health problems in frontline healthcare workers after the first outbreak of COVID-19 in China: a cross-sectional study. Health Qual Life Outcomes. 2021;19(1):1-10.
Li W, Zhang H, Zhang C, Luo J, Wang H, Wu H, et al. The Prevalence of Psychological Status During the COVID-19 Epidemic in China: A Systemic Review and Meta-Analysis. Front Psychol. 2021;12(May):1-12.
Mohammadian-Khonsari N, Shafiee G, Zandifar A, Mohammad-Poornami S, Ejtahed HS, Asayesh H, et al. Comparison of psychological symptoms between infected and non-infected COVID-19 health care workers. BMC Psychiatry. 2021;21(1):1-9.
Ozamiz-Etxebarria N, Dosil-Santamaria M, Picaza-Gorrochategui M, Idoiaga-Mondragon N. Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cad Saude Publica. 2020;36(4):1-9.
Zhang Z, Feng Y, Song R, Yang D, Duan X. Prevalence of psychiatric diagnosis and related psychopathological symptoms among patients with COVID-19 during the second wave of the pandemic. Global Health. 2021;17(1):1-12.
Presidencia de la República del Perú. Decreto Supremo Nro. N° 068-2020-PCM. https://cdn.www.gob.pe/uploads/document/file/1004305/DS_N__068-2020-PCM.pdf
Diaz V, Rivera J, Toledo P, Pozo G, Ortega A, Rendón J, et al. Aspectos clínicos de la COVID-19 en pacientes diabéticos. Diabetes Int y Endocrinol. 2020;XII(1):11-21.
Holmes E, O’Connor R, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry. 2020;7(7):547-560.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Res Ther. 2020;12(1):10-12.
Alamrawy RG, Fadl N, Khaled A. Psychiatric morbidity and dietary habits during COVID-19 pandemic: a cross-sectional study among Egyptian Youth (14–24 years). Middle East Curr Psychiatry. 2021;28(1).
Pilat TL, Alekseenko SN, Krutova VA, Amikov M, Radysh I, Umnova T, et al. Nutritional problems of patients infected with covid-19 and potential for nutritional management of disorders. Meditsinskiy Sov. 2021;2021(4):144-154.
Taylor S, Landry CA, Paluszek MM, Fergus TA, McKay D, Asmundson GJG. COVID stress syndrome: Concept, structure, and correlates. Depress Anxiety. 2020;37(8):706-714.
Taylor S, Landry CA, Paluszek MM, Fergus TA, Mckay D, Asmundson GJG. Development and initial validation of the COVID Stress Scales. J Anxiety Disorders 2020;72:102232.
Wu M, Han H, Lin T, Chen M, Wu J, Du X, et al. Prevalence and risk factors of mental distress in China during the outbreak of COVID-19: A national cross-sectional survey. Brain Behav. 2020;10(11):e01818.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 AVFT – Archivos Venezolanos de Farmacología y Terapéutica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
